Brellium Inc.
PrivateLast Round
Series B
Oct 13, 2026
Est. Valuation
$54M
Total Funding Raised
$50.84M
Momentum
Top 1%
of companies Caplight tracks
Company Overview
Brellium Inc. is a healthcare technology company that provides an AI-powered clinical compliance platform designed to audit medical charts in real-time, ensuring clinical and billing standards are met.
Sector
Healthcare & Life Sciences
Verticals
Compliance & Risk, EHR & EMR, Medical AI, Revenue Cycle, Mental Health
Business Model
B2B
Customer Profile
Subscription SaaS, Usage-Based SaaS
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Brellium Inc. Comparables
Compare Brellium Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Imprivata | 71% | |
| Dolbey and Company, Inc. | 54% | |
| Readily | 51% |
Brellium Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Oct 13, 2026 | ||||
| Series A | Apr 17, 2025 | ||||
| Seed | Nov 1, 2024 |
Key People
Founding team and executive leadership
Brellium Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Kearny Jackson | Series A |
| Necessary Ventures | Series A |
| First Round Capital | Seed, Series B, Series A |
| Fiat Ventures | Seed, Series A |
| Left Lane Capital | Series B, Series A |
| Menlo Ventures | Seed, Series A |
| Fiat Ventures | Seed, Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 13, 2026
$23M round led by First Round Capital and Left Lane Capital.
- Aug 21, 2026
Monthly visitors increased 88% MoM.
Recent news
Latest coverage and updates
- receives_financingOct 13, 2026
Brellium, Inc. receives $23M in venture funding led by Left Lane Capital and First Round Capital, with Digital Health Venture Partners participating, on Oct 13th '26 in New York to support additional clinical specialties and deeper revenue-cycle work.
- launchesOct 13, 2026
Brellium, Inc. introduces CortexLM, which analyzes patient notes to identify documentation gaps, coding errors, and compliance risks before claims reach payers.
Brellium Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Brellium Inc.'s valuation, stock price, and market status.
Is Brellium Inc. a public or private company?
Brellium Inc. is a private company.
What is the current stock price of Brellium Inc.?
Brellium Inc. is a private company, so its shares have no public market price. Caplight tracks Brellium Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Brellium Inc. worth (valuation)?
Brellium Inc.'s valuation is estimated at $54.0M based on funding round data.
Can I buy Brellium Inc. stock?
Brellium Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Brellium Inc.'s last funding round?
Brellium Inc.'s most recent funding round was Series B on October 13, 2026.
Who are the main investors in Brellium Inc.?
Key investors in Brellium Inc. include First Round Capital, Left Lane Capital, Menlo Ventures.
Will Brellium Inc. IPO soon?
No public IPO plans have been announced for Brellium Inc..
How can I track Brellium Inc. secondary market activity?
Caplight tracks bids, offers, and trades in Brellium Inc.'s shares on secondary markets.